Ceribell (CBLL) EBITDA (2023 - 2026)
Ceribell (CBLL) posted EBITDA of -$20.7 million for Q1 2026, down 42.13% on a QoQ basis from -$14.6 million in Q4 2025, and down 46.02% year-over-year from -$38.4 million in Q1 2025.
Ceribell (CBLL) EBITDA (2023 - 2026) Analysis & Trends
Ceribell's EBITDA history runs 4 years deep, the most recent figure standing at -$20.7 million for Q1 2026.
- Quarterly EBITDA fell 46.02% year-over-year to -$20.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$64.9 million (down 42.84% YoY) and the FY2025 annual result came in at -$58.4 million, down 47.07% from the prior year.
- EBITDA was -$20.7 million for Q1 2026 at Ceribell, down from -$14.6 million in the prior quarter.
- Across five years, EBITDA topped out at -$7.2 million in Q3 2023 and bottomed at -$20.7 million in Q1 2026.
- A 4-year average of -$12.2 million and a median of -$12.9 million in 2024 frame the typical range for EBITDA.
- Peak annual rise in EBITDA reached 13.29% in 2025, while the deepest fall reached 77.26% in 2025.
- Ceribell's EBITDA stood at -$8.4 million in 2023, then sank by 53.73% to -$12.9 million in 2024, then retreated by 13.29% to -$14.6 million in 2025, then slumped by 42.13% to -$20.7 million in 2026.
- Business Quant data shows CBLL's EBITDA at -$20.7 million in Q1 2026, -$14.6 million in Q4 2025, and -$14.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 477.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 255.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 515.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Ceribell | 613.16 Mn | 471.97 Mn | 23.12 Mn | -20.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.75 Mn |
| Dec 31, 2025 | -14.60 Mn |
| Sep 30, 2025 | -14.65 Mn |
| Jun 30, 2025 | -14.95 Mn |
| Mar 31, 2025 | -14.21 Mn |
| Dec 31, 2024 | -12.88 Mn |
| Sep 30, 2024 | -9.94 Mn |
| Jun 30, 2024 | -8.44 Mn |
| Mar 31, 2024 | -8.45 Mn |
| Dec 31, 2023 | -8.38 Mn |
| Sep 30, 2023 | -7.16 Mn |